Early prediction of intensive care unit-acquired weakness using easily available parameters: A prospective observational study

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Wieske, Luuk ^a   Witteveen, Esther ^a   Verhamme, Camiel ^a   Dettling Ihnenfeldt, Daniela S ^a   Van Der Schaaf, Marike ^a   Schultz, Marcus J ^a   Van Schaik, Ivo N ^a   Horn, Janneke ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; LACTIC ACID;

ADULT; AGE; ANTIBIOTIC THERAPY; APACHE IV; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; INTENSIVE CARE UNIT ACQUIRED WEAKNESS; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH COUNCIL SCALE; MUSCLE STRENGTH; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSERVATIONAL STUDY; PREDICTION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; VALIDATION STUDY; WEAKNESS; ADVERSE EFFECTS; AGED; ARTIFICIAL VENTILATION; INTENSIVE CARE UNIT; MIDDLE AGED; MUSCLE WEAKNESS; PREDICTIVE VALUE; STATISTICS AND NUMERICAL DATA;

AGED; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE WEAKNESS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL;

EID: 84908614657     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111259     Document Type: Article

References (40)

1. Stevens RD, Marshall SA, Cornblath D.R., Hoke A., Needham DM, et al. (2009) A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med 37: S299-308.
2. Latronico N, Bolton CF (2011) Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 10: 931-941.
3. Latronico N, Shehu I, Seghelini E (2005) Neuromuscular sequelae of critical illness. Curr Opin Crit Care 11: 381-390.
4. Ali NA, O'Brien JM, Hoffmann SP, Phillips G, Garland A., et al. (2008) Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 178: 261-268.
5. Sharshar T, Bastuji-Garin S, Stevens R.D., Durand M-C, Malissin I, et al. (2009) Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit Care Med 37: 3047-3053.
6. Khan J, Harrison TB, Rich M.M., Moss M (2006) Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 67: 1421-1425.
7. Tennilä A, Salmi T, Pettilä V, Roine RO, Varpula T, et al. (2000) Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 26: 1360-1363.
8. Latronico N, Shehu I, Guarneri B (2009) Use of electrophysiologic testing. Crit Care Med 37: S316-S320.
9. Novak KR, Nardelli P, Cope T.C., Filatov G., Glass JD, et al. (2009) Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats. J Clin Invest 119: 1150-1158.
10. Hough CL, Lieu BK, Caldwell ES (2011) Manual muscle strength testing of critically ill patients: feasibility and interobserver agreement. Crit Care 15: R43.
11. Stevens RD, Dowdy DW, Michaels R.K., Mendez-Tellez PA, Pronovost PJ, et al. (2007) Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 33: 1876-1891.
12. De Letter MA, Schmitz PI, Visser L.H., Verheul FA, Schellens RL, et al. (2001) Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29: 2281-2286.
13. Bednarík J, Vondracek P, Dusek L., Moravcova E, Cundrle I (2005) Risk factors for critical illness polyneuromyopathy. J Neurol 252: 343-351.
14. Bossuyt PM, Reitsma JB, Bruns D.E., Gatsonis CA, Glasziou PP, et al. (2003) The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. The Standards for Reporting of Diagnostic Accuracy Group. Ann Intern Med 44: 639-650.
15. Van Swieten JC, Koudstaal PJ, Visser M.C., Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19: 604-607.
16. Sessler CN, Gosnell MS, Grap M.J., Brophy GM, O'Neal PV, et al. (2002) The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 166: 1338-1344.
17. Vanpee G, Hermans G, Segers J., Gosselink R (2014) Assessment of limb muscle strength in critically ill patients: a systematic review. Crit Care Med 42: 701-711.
18. Steyerberg EW, Eijkemans MJ, Harrell F.E., Habbema JD (2001) Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Making 21: 45-56.
19. Brunelli A, Rocco G (2006) Internal validation of risk models in lung resection surgery: bootstrap versus training-and-test sampling. J Thorac Cardiovasc Surg 131: 1243-1247.
20. Akaike H (1974) A new look at the statistical model identification. Autom Control IEEE Trans 19: 716-723.
21. Pencina MJ, D'Agostino Ralph B S, Steyerberg EW (2010) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30: 11-21.
22. Heymans MW, van Buuren S, Knol DL, van Mechelen W, de Vet HCW (2007) Variable selection under multiple imputation using the bootstrap in a prognostic study. BMC Med Res Methodol 7: 33.
23. De Jonghe B, Cook D, Sharshar T., Lefaucheur J-P, Carlet J, et al. (1998) Acquired neuromuscular disorders in critically ill patients: a systematic review. Groupe de Reflexion et d'Etude sur les Neuromyopathies En Reanimation. Intensive Care Med 24: 1242-1250.
24. Nanas S, Kritikos K, Angelopoulos E., Siafaka A, Tsikriki S, et al. (2008) Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit. Acta Neurol Scand 118: 175-181.
25. Weber-Carstens S, Deja M, Koch S., Spranger J, Bubser F, et al. (2010) Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care 14: R119.
26. Anastasopoulos D, Kefaliakos A, Michalopoulos A (2011) Is plasma calcium concentration implicated in the development of critical illness polyneuropathy and myopathy? Crit Care 15: R247.
27. Weber-Carstens S, Koch S, Spuler S., Spies CD, Bubser F, et al. (2009) Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients. Crit Care Med 37: 2632-2637.
28. Cartwright MS, Kwayisi G, Griffin L.P., Sarwal A., Walker FO, et al. (2013) Quantitative neuromuscular ultrasound in the intensive care unit. Muscle Nerve 47: 255-259.
29. Grimm A, Teschner U, Porzelius C., Ludewig K, Zielske J, et al. (2013) Muscle ultrasound for early assessment of critical illness neuromyopathy in severe sepsis. Crit Care 17: R227.
30. Bolton CF (2005) Neuromuscular manifestations of critical illness. Muscle Nerve 32: 140-163.
31. Marshall JC (2001) Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 29: S99-106.
32. Maramattom BV, Wijdicks EFM (2006) Acute neuromuscular weakness in the intensive care unit. Crit Care Med 34: 2835-2841.
33. Puthucheary Z, Montgomery H, Moxham J., Harridge S, Hart N (2010) Structure to function: muscle failure in critically ill patients. J Physiol 588: 4641-4648.
34. Moons KGM, Kengne AP, Woodward M, Royston P., Vergouwe Y, et al. (2012) Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart 98: 683-690.
35. Moons KGM, Kengne AP, Grobbee D.E., Royston P., Vergouwe Y, et al. (2012) Risk prediction models: II. External validation, model updating, and impact assessment. Heart 98: 691-698.
36. Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G (2014) Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane database Syst Rev 1: CD006832.
37. Brunner R, Rinner W, Haberler C., Kitzberger R, Sycha T, et al. (2013) Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial. Crit Care 17: R213.
38. Ruff RL, Secrist D (1984) Inhibitors of prostaglandin synthesis or cathepsin B prevent muscle wasting due to sepsis in the rat. J Clin Invest 73: 1483-1486.
39. Erbaş O, Yeniel AÖ, Akdemir A, Ergenoʇlu AM, Yilmaz M, et al. (2013) The beneficial effects of levetiracetam on polyneuropathy in the early stage of sepsis in rats: electrophysiological and biochemical evidence. J Invest Surg 26: 312-318.
40. Erbaş O, Ergenoglu AM, Akdemir A, Yeniel AÖ, Taskiran D (2013) Comparison of melatonin and oxytocin in the prevention of critical illness polyneuropathy in rats with experimentally induced sepsis. J Surg Res 183: 313-320.